Caruut said:Well, EPO was approved by USFDA in 1989. Maybe he was an early adopter in smaller quantities. He made 2 large steps, from relative obscurity to super-domestique (top 20 Tour and top 10 Vuelta) and then from super-domestique to multiple GT winner. The first occurred when EPO was first produced, the second when it really hit cycling.
...actually was approved in Europe in late 88 and stocks from clinical trials were were being jobbed around in the cycling community earlier than that...though that in itself doesn't prove anything specific...just an important part of the background that existed at the time and against which some miracle turnarounds in performance could be judged...
Cheers
blutto